Yun Seo Jang, Il Yun, Yu Shin Park, Eun-Cheol Park, Jaeyong Shin
{"title":"住院医师制度的实施与癌症患者住院死亡率:基于国民健康保险队列数据。","authors":"Yun Seo Jang, Il Yun, Yu Shin Park, Eun-Cheol Park, Jaeyong Shin","doi":"10.1002/cam4.71207","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Hospitalists are directly responsible for inpatients, from hospitalization to discharge. Recently, Korea has started reimbursing hospitalist inpatient services. However, evidence of hospitalists being associated with improved healthcare quality is lacking. We investigated the association between the hospitalist system and reduced in-hospital mortality among patients with cancer.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This national population-based retrospective cohort study included 398,732 patients with cancer from tertiary and general hospitals with hospitalists whose data were extracted from the Korean National Health Insurance Service Cohort Database in 2021. In-hospital mortality data was obtained, defined as the presence of a record of death between admission and discharge. To increase comparability, we performed a 1:3 propensity score matching based on sex, age, hospital type, hospital region, Charlson Comorbidity Index (CCI), and primary cancer type. We used generalized estimation equation models to estimate the adjusted odds ratios (OR) for in-hospital mortality.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Patients under the hospitalist system had a lower risk of in-hospital mortality (OR: 0.91; 95% CI: 0.87–0.96). Specifically, patients in their 80s (OR = 0.31; 95% confidence interval [CI]: 0.19–0.52) and those with high CCI (OR = 0.93; 95% CI: 0.87–0.99) had a more significant association with lower in-hospital mortality.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Hospitalist services are associated with reduced in-hospital mortality rates in cancer patients, which may be influenced by continuous patient management and expertise. Our results highlight the need for dedicated personnel stationed in hospital wards for improved outcomes of patients with cancer. Our results may encourage the government to consider the expansion of the current policies for efficient allocation of healthcare resources among hospitals in Korea.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 19","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71207","citationCount":"0","resultStr":"{\"title\":\"Implementation of the Hospitalist System and In-Hospital Mortality Among Patients With Cancer: Using the National Health Insurance Cohort Data\",\"authors\":\"Yun Seo Jang, Il Yun, Yu Shin Park, Eun-Cheol Park, Jaeyong Shin\",\"doi\":\"10.1002/cam4.71207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>Hospitalists are directly responsible for inpatients, from hospitalization to discharge. Recently, Korea has started reimbursing hospitalist inpatient services. However, evidence of hospitalists being associated with improved healthcare quality is lacking. We investigated the association between the hospitalist system and reduced in-hospital mortality among patients with cancer.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>This national population-based retrospective cohort study included 398,732 patients with cancer from tertiary and general hospitals with hospitalists whose data were extracted from the Korean National Health Insurance Service Cohort Database in 2021. In-hospital mortality data was obtained, defined as the presence of a record of death between admission and discharge. To increase comparability, we performed a 1:3 propensity score matching based on sex, age, hospital type, hospital region, Charlson Comorbidity Index (CCI), and primary cancer type. We used generalized estimation equation models to estimate the adjusted odds ratios (OR) for in-hospital mortality.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Patients under the hospitalist system had a lower risk of in-hospital mortality (OR: 0.91; 95% CI: 0.87–0.96). Specifically, patients in their 80s (OR = 0.31; 95% confidence interval [CI]: 0.19–0.52) and those with high CCI (OR = 0.93; 95% CI: 0.87–0.99) had a more significant association with lower in-hospital mortality.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Hospitalist services are associated with reduced in-hospital mortality rates in cancer patients, which may be influenced by continuous patient management and expertise. Our results highlight the need for dedicated personnel stationed in hospital wards for improved outcomes of patients with cancer. Our results may encourage the government to consider the expansion of the current policies for efficient allocation of healthcare resources among hospitals in Korea.</p>\\n </section>\\n </div>\",\"PeriodicalId\":139,\"journal\":{\"name\":\"Cancer Medicine\",\"volume\":\"14 19\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71207\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71207\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71207","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Implementation of the Hospitalist System and In-Hospital Mortality Among Patients With Cancer: Using the National Health Insurance Cohort Data
Introduction
Hospitalists are directly responsible for inpatients, from hospitalization to discharge. Recently, Korea has started reimbursing hospitalist inpatient services. However, evidence of hospitalists being associated with improved healthcare quality is lacking. We investigated the association between the hospitalist system and reduced in-hospital mortality among patients with cancer.
Methods
This national population-based retrospective cohort study included 398,732 patients with cancer from tertiary and general hospitals with hospitalists whose data were extracted from the Korean National Health Insurance Service Cohort Database in 2021. In-hospital mortality data was obtained, defined as the presence of a record of death between admission and discharge. To increase comparability, we performed a 1:3 propensity score matching based on sex, age, hospital type, hospital region, Charlson Comorbidity Index (CCI), and primary cancer type. We used generalized estimation equation models to estimate the adjusted odds ratios (OR) for in-hospital mortality.
Results
Patients under the hospitalist system had a lower risk of in-hospital mortality (OR: 0.91; 95% CI: 0.87–0.96). Specifically, patients in their 80s (OR = 0.31; 95% confidence interval [CI]: 0.19–0.52) and those with high CCI (OR = 0.93; 95% CI: 0.87–0.99) had a more significant association with lower in-hospital mortality.
Conclusions
Hospitalist services are associated with reduced in-hospital mortality rates in cancer patients, which may be influenced by continuous patient management and expertise. Our results highlight the need for dedicated personnel stationed in hospital wards for improved outcomes of patients with cancer. Our results may encourage the government to consider the expansion of the current policies for efficient allocation of healthcare resources among hospitals in Korea.
期刊介绍:
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.
Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.
Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.